Vancouver, BC – June 1, 2021 – Molecular You, the Vancouver-based data-driven health intelligence company, today announced the signing of a Master Services Agreement with Hoffmann-La Roche Limited (Roche Canada). This agreement enables Roche to use Molecular You’s comprehensive molecular profiling technology.

“We are very proud of this agreement with Roche,” said Molecular You President, CEO and co-founder Rob Fraser, “as Roche shares our vision to provide patient-centred and evidence-based care. Together, our world-leading teams and technologies will enable a data-driven care model that treats not just the disease but also the patient suffering from that disease.” 

“Current medical care often employs a “one-size-fits-all” approach that ignores the fact that we are all very different from one another” notes Molecular You co-founder and Board Chair Professor Pieter Cullis. The detailed molecular-level profiles prepared by Molecular You provide the insight needed to individualize patient care and practice effective preventive medicine. Dr. Cullis, author of The Personalized Medicine Revolution, adds that “the agreement with Roche provides an important validation of the potential of Molecular You’s technology to improve healthcare.” 

Both Molecular You and Hoffmann-La Roche Limited (Roche Canada) — among many other partners are involved with the Government of Canada’s Digital Technology Supercluster and are working together on two already announced projects including:  “Personal Health Wallet” using blockchain tech to unlock the ability to securely share private health info,” (; and "Reduce Risk: Post-COVID Analytics Platform for Returning to Work” ( .


About Molecular You

Molecular You is a Health Intelligence company, founded in Vancouver Canada by a team of world leading scientists and clinicians with a unified passion to make personalized healthcare a reality.    Molecular You analyzes an individual’s current health status using multi-omic, molecular profiling.  Assisted by AI, these profiles are compared to the Molecular You global database of scientific and clinical literature to discern trends towards disease and other health risks.  Individuals receive a personalized action plan that provides guidance on how to take charge of current and future health risks. This level of personalization is unprecedented and fosters greater engagement in an individual’s health.    By aggregating the real-world data, Molecular You generates a continuous stream of insights to accelerate the evolution of holistic care and development of more effective therapies. 

Recently recognized by the world’s leading research and advisory company as a ‘2019 Gartner Cool Vendor in Healthcare Artificial Intelligence (AI).



Daniel Paquette, dpPR for Molecular You

(647) 874-2176;

Back to news